Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGX | REGN | ALNY | ||
| Company | Argenx Se ADR | Regeneron Pharmaceuticals | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 914.15 | 669.11 | 318.50 | ||
| High | 920.30 | 670.35 | 325.37 | ||
| Low | 906.23 | 661.43 | 316.77 | ||
| Latest | 915.30 | 662.88 | 323.50 | ||
| Change | -4.64 | -13.35 | +1.91 | ||
| % Change | -0.50% | -1.97% | +0.59% | ||
| Volume | 245,355 | 746,728 | 897,689 | ||
| 20-Day Average Volume | 386,088 | 1,060,566 | 1,233,349 | ||
| Previous Close | 919.94 | 676.23 | 321.59 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 894.91 | 625.96 | 295.60 | ||
| 20-Day Raw Stochastic | 66.95% | 81.88% | 96.42% | ||
| 20-Day Relative Strength | 57.68 | 54.37 | 63.04 | ||
| Weighted Alpha | +54.75 | +9.32 | -5.84 | ||
| Today's Opinion | 88% Buy | 40% Sell | 40% Sell | ||
| Previous Opinion | 88% Buy | 40% Sell | 40% Sell | ||
| Last Month's Opinion | 56% Buy | 72% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.34% since 06/30/26 | +6.31% since 06/30/26 | +7.46% since 06/30/26 | ||
| Low | 898.15 on 07/01/26 | 623.89 on 07/01/26 | 301.50 on 07/01/26 | ||
| High | 953.58 on 07/02/26 | 677.92 on 07/07/26 | 325.37 on 07/08/26 | ||
| 1-Month | |||||
| %Chg | +3.73% since 06/08/26 | +8.43% since 06/08/26 | +10.73% since 06/08/26 | ||
| Low | 837.74 on 06/24/26 | 594.90 on 06/22/26 | 273.11 on 06/18/26 | ||
| High | 953.58 on 07/02/26 | 677.92 on 07/07/26 | 325.37 on 07/08/26 | ||
| 3-Month | |||||
| %Chg | +16.59% since 04/08/26 | -14.53% since 04/08/26 | -1.15% since 04/08/26 | ||
| Low | 754.84 on 04/29/26 | 591.52 on 06/02/26 | 273.11 on 06/18/26 | ||
| High | 953.58 on 07/02/26 | 772.45 on 04/09/26 | 343.36 on 04/14/26 | ||
| 6-Month | |||||
| %Chg | +15.05% since 01/08/26 | -17.24% since 01/08/26 | -19.00% since 01/08/26 | ||
| Low | 661.85 on 03/20/26 | 591.52 on 06/02/26 | 273.11 on 06/18/26 | ||
| High | 953.58 on 07/02/26 | 821.11 on 01/09/26 | 409.58 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 57,209,220 | 71,491,032 | 42,936,444 | ||
| Shares Outstanding, K | 62,188 | 105,720 | 133,513 | ||
| Annual Sales | 4,248,050,000 | 14,342,900,000 | 3,713,940,000 | ||
| Annual Net Income | 1,292,040,000 | 4,504,900,000 | 313,750,000 | ||
| Last Quarter Sales | 1,313,000,000 | 3,605,400,000 | 1,167,180,000 | ||
| Last Quarter Net Income | 366,000,000 | 727,200,000 | 205,990,000 | ||
| 60-Month Beta | 0.45 | 0.24 | 0.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 5.52 on 05/07/26 | 9.47 on 04/29/26 | 1.99 on 04/30/26 | ||
| Earnings Date | 07/30/26 | 07/30/26 | 07/30/26 | ||
| Most Recent Dividend | N/A | 0.940 on 05/20/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 05/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 40.82 | 17.49 | 85.76 | ||